Answers are grounded in this paper and cite their sources.
Characterizes immune-metabolic responses in lung cancer patients, suggesting enhanced risk stratification techniques.
Lung cancer resection is usually associated with surgical stress and systemic immune-metabolic shifts. Existing prognostic tools largely depend on static parameters. We aimed to characterize early perioperative Systemic Immune-Inflammation Index (SII) response patterns and construct a predictive nomogram to risk-stratify patients undergoing lung cancer resection. We selected patients with malignant lung neoplasms who underwent resection and had complete perioperative laboratory records from the INSPIRE database (2011–2020). Gaussian finite-mixture modeling within an LCGA framework was applied to classify early SII response patterns from baseline to 24 h postoperatively. Primary and secondary endpoints were overall survival (OS) and intensive care unit (ICU) length of stay, respectively. A perioperative immune-metabolic stress index (PIMSI) nomogram via multivariable logistic regression was established to predict the high-risk Severe Surge response pattern and was internally validated using bootstrap resampling. A total of 2,186 patients were included and classified into three early perioperative SII response patterns: Class 1 (Stable; 57.4%), Class 2 (Moderate Increase; 35.8%), and Class 3 (Severe Surge; 6.8%). Compared with the Stable group, patients in the Severe Surge group had longer ICU stays and a higher risk of 5-year mortality (Hazard Ratio [HR] = 2.38, 95% Confidence Interval [CI]: 1.69–3.35, p < 0.001). The PIMSI model, incorporating diabetes history, preoperative C-reactive protein, operative time, prognostic nutritional index, body weight, age, and ASA physical status, showed good discrimination for identifying patients at risk of a Severe Surge response pattern (apparent AUC, 0.828; optimism-corrected AUC, 0.820) and demonstrated clinical net benefit on decision curve analysis. Early perioperative SII trajectories were associated with ICU dependency and prognosis after lung cancer resection. The PIMSI nomogram may support early risk stratification and perioperative care escalation, but it needs further validation with oncological staging and histological adjustment.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: